Identifying causes of balance impairment and exploring sensory contributions to balance in pediatric oncology: A scoping review

IF 5.5 2区 医学 Q1 HEMATOLOGY Critical reviews in oncology/hematology Pub Date : 2024-06-22 DOI:10.1016/j.critrevonc.2024.104425
Emily McCarthy , Victoria G. Marchese , Andrea G. Shipper , Kelly Rock , Cara Felter
{"title":"Identifying causes of balance impairment and exploring sensory contributions to balance in pediatric oncology: A scoping review","authors":"Emily McCarthy ,&nbsp;Victoria G. Marchese ,&nbsp;Andrea G. Shipper ,&nbsp;Kelly Rock ,&nbsp;Cara Felter","doi":"10.1016/j.critrevonc.2024.104425","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To identify causes of balance impairment in children undergoing treatment for cancer and childhood cancer survivors.</p></div><div><h3>Methods</h3><p>A systematic search was performed according to PRISMA guidelines. Studies were included if participants were 0–19 years of age with a current/past diagnosis of cancer, an objective balance measure was reported, and a cause of balance impairment was either stated or implied.</p></div><div><h3>Results</h3><p>The 64 full text studies included identified balance impairments as sequelae secondary to CNS tumors, and/or as an effect of medical treatment including chemotherapy, radiation, and/or surgery. Cancer treatment can result in damage to the visual, vestibular and/or somatosensory systems which in turn can contribute to balance dysfunction.</p></div><div><h3>Conclusions</h3><p>Balance impairments were caused by the cancer itself or the result of medical treatment. Oncology professionals are integral in recognition and treatment of factors affecting balance impairments in childhood cancer; however, further research is needed to identify interventions targeting specific causes of balance impairment.</p></div>","PeriodicalId":11358,"journal":{"name":"Critical reviews in oncology/hematology","volume":null,"pages":null},"PeriodicalIF":5.5000,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical reviews in oncology/hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1040842824001689","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To identify causes of balance impairment in children undergoing treatment for cancer and childhood cancer survivors.

Methods

A systematic search was performed according to PRISMA guidelines. Studies were included if participants were 0–19 years of age with a current/past diagnosis of cancer, an objective balance measure was reported, and a cause of balance impairment was either stated or implied.

Results

The 64 full text studies included identified balance impairments as sequelae secondary to CNS tumors, and/or as an effect of medical treatment including chemotherapy, radiation, and/or surgery. Cancer treatment can result in damage to the visual, vestibular and/or somatosensory systems which in turn can contribute to balance dysfunction.

Conclusions

Balance impairments were caused by the cancer itself or the result of medical treatment. Oncology professionals are integral in recognition and treatment of factors affecting balance impairments in childhood cancer; however, further research is needed to identify interventions targeting specific causes of balance impairment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
确定平衡障碍的原因并探索感官对儿科肿瘤平衡的影响:范围审查。
目的:确定导致接受癌症治疗的儿童和儿童癌症幸存者平衡障碍的原因:根据 PRISMA 指南进行了系统性检索。如果研究对象年龄在 0-19 岁之间,当前/既往诊断为癌症,报告了客观的平衡测量结果,并且说明或暗示了造成平衡障碍的原因,则纳入研究:纳入的 64 项全文研究发现,平衡障碍是继发于中枢神经系统肿瘤的后遗症,和/或化疗、放疗和/或手术等药物治疗的影响。癌症治疗可导致视觉、前庭和/或体感系统受损,进而造成平衡功能障碍:结论:平衡障碍是由癌症本身或药物治疗造成的。肿瘤学专业人员在识别和治疗影响儿童癌症患者平衡障碍的因素方面发挥着不可或缺的作用;但是,还需要进一步研究,以确定针对平衡障碍具体原因的干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.00
自引率
3.20%
发文量
213
审稿时长
55 days
期刊介绍: Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
期刊最新文献
The integration of radiotherapy with systemic therapy in advanced triple-negative breast cancer Investigating the role of the intratumoral microbiome in thyroid cancer development and progression Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics The role of hyperthermia in the treatment of tumor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1